Pfizer Delays Generic Lipitor Release Until 2011

digg Share this on Facebook Huffpost - Pfizer Delays Generic Lipitor Release Until 2011 stumble reddit del.ico.us RSS


First Posted: 06-18-08 08:15 AM   |   Updated: 06-26-08 05:12 AM

I Like ItI Don’t Like It
Lipitor

Bloomberg:

Pfizer Inc. and India's Ranbaxy Laboratories Ltd. agreed to keep copies of the cholesterol pill Lipitor off the U.S. market an extra 20 months, a move that may generate an added $12 billion for the U.S. drugmaker.

Under a lawsuit settlement, Ranbaxy won't sell generic versions of Lipitor, the world's best-selling drug, until November 2011, New York-based Pfizer said today in a statement. Analysts had projected Ranbaxy would enter the market in March 2010, when the main patent expires, while Pfizer was using litigation to delay competition until 2016.

Read the whole story: Bloomberg

Pfizer Inc. and India's Ranbaxy Laboratories Ltd. agreed to keep copies of the cholesterol pill Lipitor off the U.S. market an extra 20 months, a move that may generate an added $12 billion for the U.
Pfizer Inc. and India's Ranbaxy Laboratories Ltd. agreed to keep copies of the cholesterol pill Lipitor off the U.S. market an extra 20 months, a move that may generate an added $12 billion for the U.
Filed by Ben Goldberger  |  Report Corrections
 
Comments
0
Pending Comments
0
iPhone App Promo

Want to reply to a comment? Hint: Click "Reply" at the bottom of the comment; after being approved your comment will appear directly underneath the comment you replied to

View Comments:
Comments are closed for this entry

 You must be logged in to comment. Log in  or connect with 

Connect